Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gmo Product PlatformTSE:3695 -0.49%71 Days Payable is 24.78 as of Jun. 2026, which is 28% below its 10-year median of 34.19. GuruFocus rates TSE:3695 with a GF Score™ of 71/100 and a GF Value™ of 円1,590.34 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 2,609 Software companies, Gmo Product Platform ranks worse than 74.09% on this metric.
The historical rank and industry rank for Gmo Product Platform's Days Payable or its related term are showing as below:
TSE:3695'
s Days Payable Range Over the Past 10 Years
Min: 23.53 Med: 34.19 Max: 67.39
Current: 23.53
During the past 13 years, Gmo Product Platform's highest Days Payable was 67.39. The lowest was 23.53. And the median was 34.19.
TSE:3695's Days Payable is ranked worse than 74.09% of 2609
companies
in the Software industry
Industry Median: 51.7
vs TSE:3695: 23.53
Gmo Product Platform's Days Payable
declined
from Jun. 2025 (27.95) to Jun. 2026 (24.78).
It may suggest that Gmo Product Platformaccelerated paying its suppliers.
The historical data trend for Gmo Product Platform's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3695 vs MSFT, ORCL, PLTR: Days Payable Comparison
For the Software - Infrastructure subindustry, Gmo Product Platform's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gmo Product Platform Days Payable vs Software Industry
For the Software industry and Technology sector, Gmo Product Platform's Days Payable distribution charts can be found below:
* The bar in red indicates where Gmo Product Platform's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Gmo Product Platform's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gmo Product Platform (TSE:3695) has a Days Payable of 24.78 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gmo Product Platform and its competitors. This is 28% below median its historical median of 34.19. Over the past decade, Gmo Product Platform's Days Payable has ranged from 23.53 to 67.39. According to the industry distribution chart, Gmo Product Platform ranks #1933 out of 2609 companies in the Software industry, placing it in the top 74.1%.
Is Gmo Product Platform's Days Payable too high?
Gmo Product Platform's current Days Payable of 24.78 is 28% below median its 10-year median of 34.19. Over the past 10 years, this metric has ranged from a low of 23.53 to a high of 67.39. The Software industry median Days Payable is 51.70. Gmo Product Platform's value of 24.78 is 52.1% below this industry median. Based on the distribution chart, Gmo Product Platform ranks #1933 out of 2609 companies in the Software industry, which is below the industry midpoint. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's Days Payable compare to MSFT and ORCL?
According to the Software industry distribution chart, Gmo Product Platform ranks #1933 out of 2609 companies for Days Payable. This places Gmo Product Platform in the lower half of its industry. The industry median Days Payable is 51.70. Gmo Product Platform's value of 24.78 is 52.1% below this benchmark. Historically, Gmo Product Platform's own Days Payable has ranged from 23.53 to 67.39 over the past decade. While the company's 10-year median is 34.19 vs. the industry median of 51.70, Gmo Product Platform has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Software company?
The median Days Payable among Software companies is 51.70, based on 2,609 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gmo Product Platform's current Days Payable of 24.78 is 52.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median Days Payable is 51.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current Days Payable is 24.78, which is 28% below median its own 10-year median of 34.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,590.34, compared to a current price of 円1,431.00 — trading 10% below its estimated fair value. The current Days Payable is 24.78, which is 28% below median its 10-year median of 34.19 and 52.1% below the Software industry median of 51.70. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current Days Payable is 24.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gmo Product Platform (TSE:3695) Overvalued in 2026?
Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued.
The current stock price of 円1,431.00 is trading 10% below its estimated GF Value™ of 円1,590.34.
GuruFocus considers Gmo Product Platform to be Modestly Undervalued.
Key valuation signals for TSE:3695:
Days Payable: 24.78 (28% below median its 10-year median of 34.19)
GF Value™: 円1,590.34 vs. price of 円1,431.00 (10% below fair value)
Industry Position: 52.1% below the Software median (#1933 of 2609)
No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score
Get the complete analysis for TSE:3695
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3695 has been successfully added to your 
